Egyptian pediatric clinical practice adapted guidelines: evidence-based [2] steroid-resistant nephrotic syndrome (SRNS) 2022

[1]  S. Bhaumik,et al.  A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist , 2022, Annals of Internal Medicine.

[2]  L. Prikhodina,et al.  KDIGO 2021 Clinical Practice Guideline for the Management of GLOMERULAR Diseases , 2022, Nephrology and Dialysis.

[3]  B. Rovin,et al.  KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.

[4]  Beata S Lipska-Zi,et al.  Genetic Steroid-Resistant Nephrotic Syndrome Overview , 2021 .

[5]  Thomas M. Kitzler,et al.  DAAM2 Variants Cause Nephrotic Syndrome via Actin Dysregulation. , 2020, American journal of human genetics.

[6]  Melissa C Brouwers,et al.  What to Do With All The AGREEs? The AGREE Portfolio of Tools to Support The Guideline Enterprise. , 2020, Journal of Clinical Epidemiology.

[7]  D. Gipson,et al.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome , 2020, Pediatric Nephrology.

[8]  S. Ozen,et al.  Childhood vasculitis. , 2020, Rheumatology.

[9]  M. Tinawi.  Update on the etiology, classification, and management of glomerular diseases , 2019, Avicenna Journal of Medicine.

[10]  S. Mane,et al.  Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children , 2019, Pediatric Nephrology.

[11]  G. Remuzzi,et al.  C3 glomerulopathy — understanding a rare complement-driven renal disease , 2019, Nature Reviews Nephrology.

[12]  F. Fervenza,et al.  Standardized classification and reporting of glomerulonephritis , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  S. Mane,et al.  Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment , 2018, Nature Communications.

[14]  R. Salomon,et al.  Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features , 2018, Kidney international reports.

[15]  S. Mane,et al.  Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[16]  A. Rule,et al.  Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. , 2017, Kidney international.

[17]  L. Herlitz,et al.  Histopathology of Glomerular Diseases , 2018 .

[18]  S. Kamphuis,et al.  European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative , 2017, Annals of the rheumatic diseases.

[19]  F. Emma,et al.  Mitochondrial cytopathies and the kidney. , 2017, Nephrologie & therapeutique.

[20]  F. Hildebrandt,et al.  Genetic testing in steroid-resistant nephrotic syndrome: when and how? , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  M. Ghoneim,et al.  Outcome of lupus nephritis after live-donor renal transplantation: single-center experience , 2016 .

[22]  Y. Amer,et al.  The 'Adapted ADAPTE': an approach to improve utilization of the ADAPTE guideline adaptation resource toolkit in the Alexandria Center for Evidence-Based Clinical Practice Guidelines. , 2015, Journal of evaluation in clinical practice.

[23]  G. Espinosa,et al.  Renal Transplantation in Systemic Lupus Erythematosus: Outcome and Prognostic Factors in 50 Cases from a Single Centre , 2014, BioMed research international.

[24]  F. Hildebrandt,et al.  Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[25]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[26]  F. Hildebrandt,et al.  Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[27]  K. Nakanishi,et al.  Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[28]  S. Bonsib,et al.  Practice guidelines for the renal biopsy , 2004, Modern Pathology.

[29]  P. McKinney,et al.  Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK , 2001, Pediatric nephrology (Berlin, West).

[30]  J. R. Scotti,et al.  Available From , 1973 .

[31]  Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. , 1981, Kidney international.